The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMeds @accessiblemeds
The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMeds  @accessiblemeds
Uploaded March 2021 | Updated November 2026, 36 minutes ago
The U.S. generics and biosimilars industry, makers of 90% of our nation's prescription medicines, has a plan to "#SecureOurMeds." We already produce billions of doses of medicine right here in America, and our plan ensures continued patient access through COVID and beyond.

Learn more about our path forward at: secureourmeds.org
The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMedsMessage from CEO Dan Leonard on Access! 2021AAM All Access Promo: Mary Beth PowersGeneric Rx Drugs: Take With Confidence (Jonnie)Join Us at GRx+Biosims 2023Highlights from Craig Burton on the Newly Released 2018 Generic Drug Access & Savings ReportFDA Biosimilars Action PlanAAMs Ashlee Koonce Shares New Exhibitor Opportunities at GRx+Biosims 2019October Can Now Afford to do More to Support Her Mental HealthTotal generic and biosimilar savings to Medicare in 2021 #GRxBiosimsSavingsReportFDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic CompetitionAAMs Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track
Association for Accessible Medicines |

The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMeds

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER